Clinical Trials Market Report 2026

Clinical Trials Market Overview

• Clinical Trials market size has reached to $127.16 billion in 2025 • Expected to grow to $135.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: The Rising Demand For New Drug Development Is Driving Growth In The Market Due To Increasing Innovation In Therapeutics • Market Trend: Innovations In Decentralized Clinical Trial Platforms Enhance Patient Engagement And Trial Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Clinical Trials Market?

Clinical trials refer to structured research studies conducted to evaluate the safety, efficacy, dosage, and side effects of pharmaceutical compounds or medical interventions in humans. These studies are carried out in multiple phases under controlled conditions to generate evidence required for regulatory approval and to support the development of new drugs and therapies. They follow strict ethical and scientific protocols to ensure data reliability and participant safety throughout the drug development process. The main service types of clinical trials are protocol development, site management or selection, data management or biostatistics, and regulatory submission support. Protocol development refers to the process of designing a structured study plan that defines objectives, methodology, patient criteria, and trial procedures to ensure scientific and regulatory compliance. These trials are conducted through different study designs, including interventional trials, observational trials, expanded access trials, and other study designs, and are categorized across various phases, such as Phase I, Phase II, Phase III, Phase IV, and other phases. They are applied across multiple indications, including oncology, cardiovascular diseases, central nervous system disorders, infectious diseases, immunological disorders, and metabolic disorders, and are utilized by different end users, such as pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes.

What Is The Clinical Trials Market Growth Forecast?

The clinical trials market size is expected to see strong growth in the next few years. It will grow to $176.32 billion by 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to adoption of AI enabled clinical trial design, expansion of precision medicine based trials, growth of decentralized and virtual trials, increasing regulatory emphasis on real world evidence, rising demand for faster drug approval timelines. Major trends in the forecast period include increasing adoption of decentralized clinical trials enabled by digital platforms, rising use of ai driven patient recruitment and trial optimization, growth of real time remote patient monitoring in clinical studies, expansion of patient centric trial designs improving retention rates, increasing outsourcing of clinical trial functions to cros.

Global Clinical Trials Market Segmentation

1) By Service Type: Protocol Development, Site Management Or Selection, Data Management Or Biostatistics, Regulatory Submission Support 2) By Study Design: Interventional Trials, Observational Trials, Expanded Access Trials, Other Study Designs 3) By Phase: Phase I, Phase II, Phase III, Phase IV, Other Phases 4) By Indication Or Therapy Area: Oncology, Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases, Immunological Disorders, Metabolic Disorders 5) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes Subsegments: 1) By Protocol Development: Study Design And Planning Services, Clinical Trial Protocol Writing Services, Dose Selection And Escalation Planning Services, Endpoint Selection And Validation Services, Risk Assessment And Mitigation Planning Services 2) By Site Management Or Selection: Investigator Site Identification Services, Site Feasibility Assessment Services, Site Initiation And Activation Services, Site Monitoring And Management Services, Patient Recruitment And Retention Support Services 3) By Data Management Or Biostatistics: Clinical Data Collection And Entry Services, Data Validation And Cleaning Services, Statistical Analysis And Modeling Services, Clinical Trial Data Reporting Services, Database Design And Management Services 4) By Regulatory Submission Support: Regulatory Documentation Preparation Services, Clinical Trial Application Submission Services, Ethics Committee Submission And Coordination Services, Regulatory Compliance Monitoring Services, Post Submission Support And Query Management Services

What Is The Driver Of The Clinical Trials Market?

The rising demand for new drug development is expected to propel the growth of the clinical trials market going forward. New drug development refers to the process of discovering, evaluating, and bringing new pharmaceutical compounds to market to address unmet medical needs. The increase in new drug development is driven by the growing need for innovative therapies to treat chronic and complex diseases, leading to a surge in research and testing activities. The clinical trials support new drug development demand by facilitating the systematic assessment of drug safety, efficacy, and regulatory compliance across various trial phases. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association that represents the pharmaceutical industry in Europe, the total pharmaceutical production in Europe accounted for €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022. Therefore, the increasing demand for new drug development is driving the growth of the clinical trials industry.

Key Players In The Global Clinical Trials Market

Major companies operating in the clinical trials market are ICON plc, WuXi AppTec Co Ltd, Charles River Laboratories International Inc, Fortrea Holdings Inc, CMIC Holdings Co Ltd, EPS Holdings Inc, Medpace Holdings Inc, Pharmaron Beijing Co Ltd, Hangzhou Tigermed Consulting Co Ltd, ClinChoice Inc, Worldwide Clinical Trials Holdings Inc, Lambda Therapeutic Research Ltd, Syngene International Ltd, Altasciences Company Inc, KCR SA, Accutest Research Laboratories India Pvt Ltd, Rho Inc

Global Clinical Trials Market Trends and Insights

Major companies operating in the clinical trials market are focusing on developing advanced solutions, such as integrated decentralized clinical trial (DCT) platforms, to enhance patient accessibility, streamline trial operations, and improve data collection efficiency. Decentralized clinical trial platforms refer to technology-driven systems that enable remote patient participation, virtual monitoring, and digital data capture, reducing the need for physical site visits and improving trial flexibility. For instance, in June 2024, IQVIA, a US-based provider of advanced analytics, technology solutions, and clinical research services, launched One Home for Sites, a unified clinical trial technology platform designed to support decentralized and hybrid trials. The platform integrates various digital capabilities, including remote patient monitoring, telehealth, eConsent, and data collection tools, into a single interface, enabling seamless trial management, improving patient engagement, and accelerating clinical research outcomes.

What Are Latest Mergers And Acquisitions In The Clinical Trials Market?

In October 2025, Thermo Fisher Scientific Inc., a US-based life sciences and clinical research company, acquired Clario for up to $9.4 billion. With this acquisition, Thermo Fisher aims to significantly strengthen its clinical trial research and data management capabilities by integrating Clario’s advanced endpoint data solutions, thereby enhancing its end-to-end clinical development services and enabling more efficient, data-driven trial execution across global studies. Clario is a US-based clinical research technology company that provides clinical trials-related services.

Regional Insights

North America was the largest region in the clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Clinical Trials Market?

The clinical trials market includes revenues earned by entities by providing services such as patient recruitment and retention services, clinical monitoring services, pharmacovigilance and safety reporting, and medical writing and documentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clinical Trials Market Report 2026?

The clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.